Astaxanthin Modulates Apoptotic Molecules to Induce Death of SKBR3 Breast Cancer Cells

Area of Science:

• Oncology
• Molecular Biology
• Cell Biology

Background:

• Astaxanthin (AST) is linked to apoptosis, but its precise mechanisms in cancer remain unclear.
• Understanding AST's role in apoptosis is crucial for developing novel cancer therapies.

Purpose of the Study:

• To investigate the detailed apoptotic effects of Astaxanthin on the SKBR3 breast cancer cell line.
• To elucidate the molecular mechanisms underlying AST-induced apoptosis.

Main Methods:

• Cell viability assays and morphological observation.
• Flow cytometry (FACS) analysis for cell cycle and apoptosis.
• Western blotting to assess protein expression (mutp53, PARP-1, Bax, Bcl-2, caspases, ERK1/2, JNK, p38).
• Measurement of intracellular reactive oxygen species (ROS) and analysis of superoxide dismutases and Pontin.
• Co-immunoprecipitation to study protein interactions.

Main Results:

• AST suppressed SKBR3 cell proliferation and induced morphological changes.
• AST caused G0/G1 cell cycle arrest and dose-dependent apoptosis.
• AST decreased mutp53 and cleaved PARP-1 levels.
• AST activated intrinsic apoptosis pathways (Bax/Bcl-2, caspase-3, caspase-9) and MAPK signaling (ERK1/2, JNK, p38).
• AST reduced intracellular ROS, modulated antioxidant enzymes, and decreased the anti-apoptotic factor Pontin.
• AST disrupted the interaction between Pontin and mutant p53.

Conclusions:

• Astaxanthin induces intrinsic apoptosis in breast cancer cells through complex molecular regulation.
• AST modulates apoptotic molecules, cell cycle progression, and ROS production.
• AST's mechanism involves downregulating Pontin-mutant p53 interaction.
• Astaxanthin holds promise as an adjunct therapy for breast cancer.